American Liver Foundation Applauds U.S. Senators Bill Cassidy and Chris Van Hollen for Introducing the Cure Hepatitis C Act under Medicare and Medicaid

“American Liver Foundation (ALF) applauds U.S. Senators Bill Cassidy, M.D. (R-LA) and Chris Van Hollen (D-MD) for introducing life-saving legislation to help cure Americans suffering from hepatitis C (HCV). The Cure Hepatitis C Act of 2025 will establish a voluntary drug subscription model to connect HCV patients to treatments and stop the spread of this disease, which also puts patients at risk for liver cancer and liver failure. Unlike treatments of the past, today’s treatment for HCV cures more than 95% of cases with almost no side effects,” said Emmanuel Thomas, MD, PhD, Board Chair, American Liver Foundation and Tenured Professor at the University of Miami School of Medicine. Dr. Thomas is also an expert in HCV and helps lead HCV elimination efforts in Florida.

“We are excited about this legislation because expanding access to HCV drugs, especially to those Americans who rely on Medicare and Medicaid, is critical to stopping a lifetime of chronic health issues, including liver cancer. This life-saving proposal empowers individuals to take preventative measures regarding their health, reduces stigma and ultimately helps people access timely testing and treatment that can improve public health outcomes,” said Lorraine Stiehl, CEO, American Liver Foundation.

For more information about hepatitis, liver disease and liver cancer, view our recent webinar: The Connection Between Viral Hepatitis and Liver Cancer.